✉news BusinessRetail first seen 5 h ago, last 1 h ago, peak #6

IBRX Stock Logs Best Week In Over 7 Months

Original: IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick

ImmunityBio shares (IBRX) posted their strongest weekly gain in more than seven months, drawing retail investor attention. Traders are betting the company's bladder cancer drug Anktiva could benefit after Donald Trump's choice to lead a cancer-focused panel, with investors hoping for policy support that may boost adoption and sales of the immunotherapy.

Why now: Retail investors are speculating that Trump's cancer panel pick could drive policy support for ImmunityBio's Anktiva, lifting the stock.

ImmunityBioIBRXAnktivaDonald Trump

Open on news →

Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 1 h ago.

Evidence

• IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick · TradingView
• IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick · Stocktwits

API: https://socialmediatrends-api.osmike.com/v1/trends/1057495